ASCO GU 2021: Nivolumab plus cabozantinib combination for the first-line treatment of advanced kidney cancer
The past couple of years has seen a number of [...]
The past couple of years has seen a number of [...]
The recent phase II KEYNOTE-427 study investigated the efficacy and [...]
A recent study published in the International Journal of Clinical [...]
The microbes in the gut (the gut microbiome) are a [...]